Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cervical Cancer Prevention Using Self-sampling and Human Papillomavirus Detection

NCT04226313 is registered in ClinicalTrials.gov with The Institute of Molecular and Translational Medicine, Czech Republic as lead sponsor.

NCT NCT04226313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04226313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cervical Cancer Prevention Using Self-sampling and Human Papillomavirus Detection
Lead sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
Phase
Not applicable
Overall status
Recruiting
Start date
September 23, 2019
Completion date
December 1, 2026
Enrollment
15,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical dysplasia, human papillomavirus infection